Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
Antiplatelet therapy for prevention of recurrent stroke
Current Treatment Options in Neurology, 10/29/09
Badruddin A et al. – When choosing an antiplatelet agent for this purpose, clinicians should take into account cost, side effect profile, medical comorbidity, and patient preference. To prevent recurrent stroke, aspirin alone (50–325 mg/d), a combination of aspirin (25 mg) plus extended–release dipyridamole (200 mg), given twice daily, or clopidogrel (75 mg/d) may be used as initial treatment. Prasugrel, a new thienopyridine derivative, more quickly and consistently inhibits platelets than clopidogrel. In stroke patients, prasugrel may be associated with a higher risk of brain hemorrhage, so it may not be indicated when there is a history of cerebrovascular disease.
Related Articles
Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature
Hypertension Research, 11/13/09
Relevance Score: 81%
Stroke-related dementia: Rates, risk factors and implications for future research
Maturitas, 11/11/09
Relevance Score: 81%
Antithrombotic medication for stroke prevention
Expert Review of Cardiovascular Therapy, 10/20/09
Relevance Score: 81%
Ischemic stroke and hyperhomocysteinemia: truth or myth
Acta Neurologica Belgica, 10/21/09
Relevance Score: 80%
Low Ankle-Brachial Index Predicts Cardiovascular Risk After Acute Ischemic Stroke or Transient Ischemic Attack
Stroke, 10/20/09
Relevance Score: 80%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09
Serum Thyroid-Stimulating Hormone Concentration and Morbidity from Cardiovascular Disease and Fractures in Patients on Long-Term Thyroxine Therapy
Journal of Clinical Endocrinology and Metabolism, 11/25/09
Emergency Influenza Drug
JAMA, 11/25/09
Today in Neurology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of cilnidipine vs losartan on cerebral blood flow in hypertensive patients with a history of ischemic stroke: a randomized controlled trial
Acta Neurologica Scandinavica, 11/25/09
Long-term Neurologic Outcomes After Traumatic Brain Injury
Journal of Head Trauma Rehabilitation, 11/25/09
Association of higher carbohydrate intake with depressive mood in elderly diabetic women
Nutritional Neuroscience, 11/25/09
Today in Preventive Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Effectiveness of Public Report Cards for Improving the Quality of Cardiac Care: The EFFECT Study: A Randomized Trial
JAMA, 11/25/09
Prospective studies of dietary alpha-linolenic acid intake and prostate cancer risk: a meta-analysis
Cancer Causes and Control, 11/25/09
Understanding Omega-3 Polyunsaturated Fatty Acids
Postgraduate Medicine, 11/24/09
Today in Vascular Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Prospective analysis of risk factors and distribution of venous thromboembolism in the population-based Malmo Thrombophilia Study (MATS)
Thrombosis Research, 11/25/09
Effect of cilnidipine vs losartan on cerebral blood flow in hypertensive patients with a history of ischemic stroke: a randomized controlled trial
Acta Neurologica Scandinavica, 11/25/09
The DD genotype of the angiotensin converting enzyme gene independently associates with CMR-derived abnormal microvascular perfusion in patients with a first anterior ST-segment elevation myocardial infarction treated with thrombolytic agents
Thrombosis Research, 11/25/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


